Why does Semaglutide keep the GLP-1 fullness effect going?
Semaglutide can reduce hunger, weight and blood sugar. Some patients also had fewer heart or kidney problems in studies, but the medicine has harms to weigh.
What can this medicine change for you?
Semaglutide can help you eat less by extending the body's response to a meal. Your gut releases GLP-1, a hormone that helps tell the brain you've eaten enough. Hormones carry messages between body parts to guide what happens next. Semaglutide acts much like GLP-1, but its effect lasts roughly a week.
Less hunger means people can feel satisfied with smaller meals and lose weight. The medicine also increases insulin, the hormone that helps blood sugar pass into cells. Food takes longer to pass from your stomach, so sugar rises less sharply after meals. Those changes help explain why both weight and blood-sugar readings can fall.
Studies found lower sugar readings in type 2 diabetes and weight loss during continued treatment. Among patients already living with heart disease, studies counted fewer strokes and heart attacks. Stomach trouble and other harms still need a place in your discussion with a doctor, and the effects page describes the symptoms that made continued treatment hard for some patients.
What changes help semaglutide last between shots?
Semaglutide has a 31-amino-acid chain; each amino acid is a small part used to form proteins [4]. That chain closely resembles GLP-1, the hormone released by your gut when a meal arrives. One amino acid is replaced at position 8 in that chain to resist rapid breakdown. An added fatty part lets semaglutide attach to a protein already in blood [5].
Attaching to that protein slows how quickly your body removes semaglutide. A shot therefore lasts about a week, while natural GLP-1 lasts only minutes. Semaglutide’s longer stay keeps the GLP-1 effect going between shots instead of fading after one meal. Those changes explain the lasting effect, without promising how much weight you'll lose.
Doctors prescribe semaglutide as weekly shots or daily tablets, which enter blood differently. Semaglutide is the medicine's general name, so different brands may use that same name. When weighing treatment, your doctor needs the form and the amount prescribed together. Your other medicines and illnesses also matter when the doctor weighs treatment.
Why did the animals lose weight when hunger fell?
Tests using rats and mice found less eating after semaglutide reached areas controlling appetite [4]. Their bodies kept using energy at rest, and the kinds of food they chose also changed. The animals lost weight chiefly because less food came in, without having to burn calories faster. These findings explain the animals' weight change, without measuring your brain.
Some brain cells urge the animal to eat, while other cells help end a meal. Drugs acting like GLP-1, the gut hormone that helps bring fullness, favored the cells that curb eating. The cell response varied with time after the drug and the animal's state of hunger [8]. That doesn't give you a fixed time when hunger will fall during treatment.
An earlier medicine in this group stopped causing weight loss in a separate mouse test. Researchers had blocked the drug's action in a small area of the brain involved in meal control [9]. The result supports that area's role in mice, while leaving questions about people. You can follow those limits on the page about how semaglutide acts.
How much did weight and serious health risks fall?
In STEP 1, overweight adults without diabetes lost weight during 68 weeks of treatment. Weekly semaglutide 2.4 mg gave average weight change of -14.9%, compared with -2.4% with placebo. Placebo means treatment containing no active medicine, used to compare what happened in each group. The extra loss was roughly a 12-percentage-point gap, meaning about twelve percent of starting weight [1].
SUSTAIN-6 found fewer heart attacks, strokes and heart-related deaths in high-risk adults with type 2 diabetes [2]. SELECT followed 17,604 adults with obesity and existing heart disease who didn't have diabetes. Their risk of those serious heart or stroke problems fell by 20%, meaning a fifth lower than the comparison group's risk [3]. Your benefit depends on your health, beyond that percentage alone.
FLOW found a 24% lower risk of serious kidney problems in type 2 diabetes with long-standing kidney disease [6]. That percentage compares risks between groups; it doesn't count how many patients will benefit. Large studies support these gains, but stomach trouble and other harms still matter for you. Read Semaglutide research alongside Semaglutide effects when weighing the benefits and the limits.
Which uses of Semaglutide have been tested in people?
Semaglutide is a peptide, a short chain made from the same parts as proteins. Human trials have tested the medicine for weight control and type 2 diabetes. Other uses include lowering certain heart risks and, since 2025, treating the liver illness called MASH [1][3][6]. MASH means liver inflammation from fat buildup; this use covers adults with moderate to advanced scarring without cirrhosis, severe scarring that changes the liver’s structure.
Those human studies tell you more than the word peptide on its own. The people followed in human studies supply evidence, alongside the approved instructions for each use. The amounts reported here explain study results; they aren't a dose chosen for you. Your health history remains part of choosing treatment, so your doctor has to weigh that background alongside the benefits and harms reported in the studies before judging what fits you.